ADC Therapeutics S.A.
ADCT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$158 | -$240 | -$157 | -$230 |
| Dep. & Amort. | $3 | $3 | $6 | $3 |
| Deferred Tax | $0 | $37 | $0 | -$26 |
| Stock-Based Comp. | $7 | $13 | $51 | $60 |
| Change in WC | $4 | $44 | -$49 | -$16 |
| Other Non-Cash | $20 | $23 | $11 | -$25 |
| Operating Cash Flow | -$124 | -$119 | -$138 | -$233 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$3 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$3 |
| Investing Cash Flow | -$1 | -$3 | -$1 | -$7 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$3 | $49 |
| Stock Issued | $61 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $37 | $74 | $3 | $219 |
| Financing Cash Flow | $97 | $74 | -$1 | $267 |
| Forex Effect | -$0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$28 | -$48 | -$140 | $27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $279 | $326 | $467 | $439 |
| End Cash | $251 | $279 | $326 | $467 |
| Free Cash Flow | -$125 | -$122 | -$139 | -$240 |